200 related articles for article (PubMed ID: 27104192)
1. Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma.
Park JA; Shin HY
Blood Res; 2016 Mar; 51(1):50-7. PubMed ID: 27104192
[TBL] [Abstract][Full Text] [Related]
2. ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
Park JA; Shin HY
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e270-e274. PubMed ID: 28267080
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
Front Pediatr; 2020; 8():307. PubMed ID: 32612964
[No Abstract] [Full Text] [Related]
4. Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis.
Huang J; Fan H; Qiu Q; Liu K; Lv S; Li J; Yang H; Shu X; Xu Y; Lu X; Lu C; Zhang Y; Xiao C
Ther Adv Chronic Dis; 2020; 11():2040622320916026. PubMed ID: 32426102
[TBL] [Abstract][Full Text] [Related]
5. Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population.
Lv S; Fan H; Li J; Yang H; Huang J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Xiao C
Front Pharmacol; 2018; 9():1390. PubMed ID: 30546311
[No Abstract] [Full Text] [Related]
6. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
7. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
Qiu Q; Huang J; Shu X; Fan H; Zhou Y; Xiao C
Sci Rep; 2017 Mar; 7():44015. PubMed ID: 28266606
[TBL] [Abstract][Full Text] [Related]
9. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
[TBL] [Abstract][Full Text] [Related]
10. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
[TBL] [Abstract][Full Text] [Related]
11. MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients.
Xu L; Wang L; Xue B; Wang S
J Bone Oncol; 2018 Nov; 13():143-147. PubMed ID: 30591868
[TBL] [Abstract][Full Text] [Related]
12. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
[TBL] [Abstract][Full Text] [Related]
13. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
[TBL] [Abstract][Full Text] [Related]
14. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients.
Ramalingam R; Kaur H; Scott JX; Sneha LM; Arunkumar G; Srinivasan A; Paul SFD
Cancer Chemother Pharmacol; 2022 Mar; 89(3):393-400. PubMed ID: 35157101
[TBL] [Abstract][Full Text] [Related]
16. A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
Lui G; Treluyer JM; Fresneau B; Piperno-Neumann S; Gaspar N; Corradini N; Gentet JC; Marec Berard P; Laurence V; Schneider P; Entz-Werle N; Pacquement H; Millot F; Taque S; Freycon C; Lervat C; Le Deley MC; Mahier Ait Oukhatar C; Brugieres L; Le Teuff G; Bouazza N;
J Clin Pharmacol; 2018 Dec; 58(12):1541-1549. PubMed ID: 29791011
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
[TBL] [Abstract][Full Text] [Related]
18. The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review.
Wang J; Zhao YT; Sun MJ; Chen F; Guo HL
Pharmgenomics Pers Med; 2022; 15():919-926. PubMed ID: 36349164
[TBL] [Abstract][Full Text] [Related]
19. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
20. Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia.
Hao Q; Song Y; Fang Q; Lin Y; Chen L; Wang X; Zhang P; Wang Z; Gong X; Liu K; Li Q; Tian Z; Wang M; Wang J; Mi Y
Blood Sci; 2023 Jan; 5(1):32-38. PubMed ID: 36742186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]